A new class of weight loss drug just took a major step toward approval for use. In a phase III clinical trial, medication ...

The GLP-1 PR has been a little too good. Everyone knows the drugs lead to rapid weight loss — including participants in supposedly “blind” drug trials. So now, when those participants don’t drop ...

Neuralink’s first brain implant in a human patient took place in January 2024, but the details of what the company’s clinical trial actually requires of participants, regulators, and the company ...

City of Hope, which earlier this month opened a new hospital in Orange County, Calif., (shown in this picture) now has a network of five specialized cancer hospitals across the country and 38 clinical ...

Announcing a new article publication for BIO Integration journal. Clinical trials bridge basic research and clinical application, serving as essential steps in drug development.

Clinical trial sites often open and close rapidly, with 60% ceasing operations within the first year, impacting patient access. The high closure rate of trial sites reflects unique research objectives ...

The National Institutes of Health will no longer categorize basic experimental studies involving humans (BESH) as clinical trials, according to a Jan. 29 announcement from the agency. BESH ...

A burdensome regulatory environment is pushing clinical trials overseas. Jacob Becraft is the co-founder and CEO of Strand Therapeutics.

New York City-based Mount Sinai’s Tisch Cancer Center has launched a new AI platform designed to help more cancer patients across its health system find and enroll in clinical trials. The platform, ...

Martei is a medical oncologist, cancer outcomes researcher, and an assistant professor of medicine at the University of Pennsylvania. At the American Society of Clinical Oncology annual meeting last ...